Sherry Chow
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Retinoids in leukemia and cellular processes 1
- Metabolism, Diabetes, and Cancer 1
-
- Inflammatory mediators and NSAID effects 2
- Pharmacological Effects of Natural Compounds 1
- Co-authors
- Ming‐Sound Tsao (1 shared paper)David W. Hedley (1 shared paper)Gillian Paine-Murrieta (1 shared paper)Ryan Williams (1 shared paper)Garth Powis (1 shared paper)Nathan T. Ihle (1 shared paper)Margareta Berggren (1 shared paper)Robert J. Halter (1 shared paper)
- Journals
- The FASEB Journal (1 paper)Journal of Nutrition (1 paper)Molecular Cancer Therapeutics (1 paper)International Journal of Molecular Sciences (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Sherry Chow
8 papers receiving 726 citations
Peers
Comparison fields: 5 of 74
- Oncology 206
- Cancer Research 91
- Molecular Biology 423
- Genetics 57
- Pathology and Forensic Medicine 66
Countries citing papers authored by Sherry Chow
This map shows the geographic impact of Sherry Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Chow more than expected).
Fields of papers citing papers by Sherry Chow
This network shows the impact of papers produced by Sherry Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Chow. The network helps show where Sherry Chow may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherry Chow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. | 2000 | 272 |
| 2 | 2004 | 265 | |
| 3 | 2008 | 59 | |
| 4 | 2018 | 51 | |
| 5 | 2016 | 46 | |
| 6 | 2021 | 39 | |
| 7 | 1999 | 8 | |
| 8 | 2017 | 1 |
About Sherry Chow
Sherry Chow is a scholar working on Molecular Biology, Pharmacology, Nutrition and Dietetics, Surgery and Oncology, having authored 8 papers that have together received 741 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Antioxidant Activity and Oxidative Stress (1 paper), Vitamin C and Antioxidants Research (1 paper), Pharmacological Effects of Natural Compounds (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Retinoids in leukemia and cellular processes (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Oncology (206 citations), Cancer Research (91 citations), Molecular Biology (423 citations), Genetics (57 citations) and Pathology and Forensic Medicine (66 citations). Sherry Chow has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Ming‐Sound Tsao, David W. Hedley, Gillian Paine-Murrieta, Ryan Williams, Garth Powis, Nathan T. Ihle, Margareta Berggren, Robert J. Halter, Peter Wipf and Lynn Kirkpatrick. Their work appears in journals such as The FASEB Journal, Journal of Nutrition, Molecular Cancer Therapeutics, International Journal of Molecular Sciences and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.